
Ask a doctor about a prescription for CEFTAZIDIME NORMON 2 g POWDER FOR SOLUTION FOR INFUSION
Package Leaflet: Information for the User
Ceftazidime Normon 2 g powder for solution for infusion EFG
ceftazidime
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the package leaflet:
Ceftazidime Normon is an antibiotic used in adults and children (including newborns). It works by killing the bacteria that cause infections. It belongs to a group of medicines known as cephalosporins.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold. It is important that you follow the instructions regarding dose, administration interval, and treatment duration as indicated by your doctor. Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash. |
Ceftazidime Normon is used to treat serious bacterial infections of:
Ceftazidime Normon can also be used:
to treat patients who have a low white blood cell count (neutropenia) and fever due to a bacterial infection.
This medicine must not be administered to you:
♦ Inform your doctorbefore starting treatment with Ceftazidime Normon if you think this applies to you. This medicine must not be administered to you.
Warnings and precautions
While you are being administered this medicine, you should be aware of certain symptoms such as allergic reactions, nervous system disorders, and gastrointestinal disorders, such as diarrhea. This will reduce the risk of potential problems. See (Symptoms to which you should pay attention) in section 4. If you have ever had an allergic reaction to other antibiotics, you may also be allergic to this medicine.
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP) have been reported in relation to ceftazidime treatment. Seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
If you need a blood or urine test
Ceftazidime Normon may affect the results of urine glucose tests and a blood test known as the Coombs test. If you are having tests:
♦ Inform the person taking the samplethat you have been administered ceftazidime.
Use of Ceftazidime Normon with other medicines
Tell your doctor if you are using, have recently used, or might use any other medicines.
This medicine must not be administered to you without talking to your doctor if you are also taking:
♦ Inform your doctorif this applies to you.
Pregnancy and breastfeeding
Tell your doctor before you are administered this medicine:
Your doctor will weigh the benefits of treating you with this medicine against the risks to the baby.
Driving and using machines
Ceftazidime Normon may cause side effects such as dizziness that affect your ability to drive.
Do not drive or operate machinery unless you are sure it does not affect you.
Ceftazidime Normon contains sodium.
This medicine contains 104.15 mg (4.53 mmol) of sodium (the main component of table salt/cooking salt) per vial. This is equivalent to 5.2% of the maximum daily intake for an adult.
This medicine is usually administered by a doctor or nurse.It is administered as a drip(intravenous infusion).
This medicine is reconstituted by the doctor, pharmacist, or nurse using a suitable infusion fluid.
Recommended dose
The correct dose of this medicine for you will be decided by your doctor and depends on: the severity and type of infection, if you are being treated with other antibiotics, your weight and age, and your kidney function.
Newborn babies (0-2 months)
For every 1 kg of the baby's weight, 25 to 60 mg of this medicine will be administered per day, divided into two doses.
Babies (over 2 months) and childrenwho weigh less than 40 kg
For every 1 kg of the baby's or child's weight,100 to 150 mg of this medicine will be administered per day, divided into three doses. Maximum 6 g per day.
Adults and adolescentswho weigh 40 kg or more
1 g to 2 g of this medicine, three times a day. Maximum 9 g per day.
Patients over 65 years of age
The daily dose should not normally exceed 3 g per day, especially if you are over 80 years old.
Patients with kidney problems
You may be administered a different dose than usual. The doctor will decide how much of this medicine you need, depending on the severity of the kidney disease. Your doctor will closely monitor you and perform kidney tests more frequently.
If you are administered more Ceftazidime Normon than you should
If you accidentally receive more than the prescribed dose, contact your doctor or the nearest hospital.
You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount administered.
If you miss a dose of Ceftazidime Normon
If you miss an injection, you should receive it as soon as possible. However, if it is almost time for the next injection, skip the missed injection. Do not use a double dose (two injections at the same time) to make up for the missed dose. Receive the next dose at the usual time.
If you stop treatment with Ceftazidime Normon
Do not stop receiving this medicine unless your doctor tells you to.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Seek medical attention immediately if you notice any of the following symptoms:
Symptoms to which you should pay attention
The following serious side effects have occurred in a small number of patients, but their exact frequency is unknown:
There have been reports of rare cases of severe hypersensitivity reactions with severe skin rash, which can be accompanied by fever, fatigue, swelling of the face or lymph nodes, increased eosinophils (a type of white blood cell), liver, kidney, or lung involvement (a reaction known as DRESS syndrome)
♦ Contact your doctor or nurse immediately if you experience any of these symptoms.
Common side effects
May affect 1 in 10people:
♦ Inform your doctorif any of these side effects worry you.
Common side effects that may appear in blood tests:
Uncommon side effects
May affect 1 in 100people:
♦ Inform your doctorif you experience any of them.
Uncommon side effects that may appear in blood tests:
Rare side effects
May affect 1 in 10,000 people:
Other side effects
Other side effects that have occurred in a small number of patients, but whose exact frequency is unknown:
Other side effects that may appear in blood tests:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's (AEMPS) website: https//www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store below 25 ºC.
Store in the original package to protect from light.
Do not use this medicine after the expiry date stated on the package after EXP. The expiry date is the last day of the month indicated.
From a microbiological point of view, the product should be used immediately. If not used immediately, the maximum validity period once the injectable is reconstituted with the indicated volume of diluent is 8 hours at a temperature of 25 ºC and 24 hours at a temperature between 2 ºC-8 ºC.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Ceftazidime Normon
The active substance is ceftazidime. Each vial contains 2 g of ceftazidime (as pentahydrate).
As an excipient, it contains anhydrous sodium carbonate.
Appearance of the product and pack contents
The Ceftazidime Normon 2 g powder for solution for infusion pack contains a 20 ml capacity vial with 2 g of ceftazidime in powder form. It is presented in packs of 1 vial or 50 vials (clinical pack).
Marketing authorization holder and manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (Spain)
Date of last revision of this leaflet:October 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CEFTAZIDIME NORMON 2 g POWDER FOR SOLUTION FOR INFUSION – subject to medical assessment and local rules.